Who Exports Diclofenac from India — 1007 Suppliers Behind a $363.9M Market
India's diclofenac export market is supplied by 1007 active exporters who collectively shipped $363.9M across 15,000 shipments. LINCOLN PHARMACEUTICALS LTD leads with a 15.5% market share, followed by COMBITIC GLOBAL CAPLET PRIVATE LIMITED and RUBICON RESEARCH PRIVATE LIMITED. The top 5 suppliers together control 42.3% of total export value, reflecting a moderately competitive market structure.
Top Diclofenac Exporters from India — Ranked by Export Value
LINCOLN PHARMACEUTICALS LTD is the leading diclofenac exporter from India, holding a 15.5% share of the $363.9M market across 15,000 shipments from 1007 exporters. The top 5 suppliers — LINCOLN PHARMACEUTICALS LTD, COMBITIC GLOBAL CAPLET PRIVATE LIMITED, RUBICON RESEARCH PRIVATE LIMITED, CIPLA LIMITED, CAPLIN POINT LABORATORIES LIMITED — collectively control 42.3% of total export value, indicating a competitive market. Individual shares are: LINCOLN PHARMACEUTICALS LTD (15.5%), COMBITIC GLOBAL CAPLET PRIVATE LIMITED (9.2%), RUBICON RESEARCH PRIVATE LIMITED (6.7%), CIPLA LIMITED (5.7%), CAPLIN POINT LABORATORIES LIMITED (5.2%).
Top Diclofenac Exporters from India
Ranked by export value · 1007 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | LINCOLN PHARMACEUTICALS LTD DICLOFENAC SODIUM WITH PARACETAMOL TABLEPARACETAMOL, DICLOFENAC SODIUM AND MAGNEDICLOFENAC SODIUM 50MG TABLET- DICLOSET | $56.3M | 22 | 15.5% |
| 2 | COMBITIC GLOBAL CAPLET PRIVATE LIMITED DICLOFENAC SODIUM AND PARACETAMOL TABLETPARACETAMOL, DICLOFENAC SODIUM AND MAGNEDICLOFENAC SODIUM, PARACETAMOL, CHLORPHE | $33.5M | 4 | 9.2% |
| 3 | RUBICON RESEARCH PRIVATE LIMITED 300036534 DICLOFENAC SODIUM TOPICAL GEL1% 100GM | $24.3M | 1 | 6.7% |
| 4 | CIPLA LIMITED 300036534 DICLOFENAC SODIUM TOPICAL GEL1% 100GM | $20.9M | 8 | 5.7% |
| 5 | CAPLIN POINT LABORATORIES LIMITED DICLOFENAC SODIUM + NEUROTROPAS SOFT GELDICLOFENAC SODIUM AND NEUROTROPAS SOFT GELATIN CAPSULESDICLOFENAC POTASSIUM TABLETS USP 50MG | $19.0M | 9 | 5.2% |
| 6 | TROIKAA PHARMACEUTICALS LIMITED DICLOFENAC SODIUM WITH PARACETAMOL TABLEDICLOFENAC SODIUM AND PARACETAMOL TABLETCHLORZOXAZONE, DICLOFENAC SODIUM & PARAC | $16.0M | 40 | 4.4% |
| 7 | ENCUBE ETHICALS PRIVATE LIMITED 300036534 DICLOFENAC SODIUM TOPICAL GEL1% 100GM | $15.4M | 2 | 4.2% |
| 8 | MICRO LABS LIMITED 300036534 DICLOFENAC SODIUM TOPICAL GEL1% 100GMDYNAPAR DICLOFENAC SODIUM AND PARACETAMODICLOFENAC SODIUM INJECTION 75 MG/3 ML ( | $12.9M | 18 | 3.6% |
| 9 | DR.REDDY'S LABORATORIES LTD 300036534 DICLOFENAC SODIUM TOPICAL GEL1% 100GM | $9.8M | 1 | 2.7% |
| 10 | SIFAM HEALTHCARE PRIVATE LIMITED DICLOFENAC SODIUM 50MG TABLET- DICLOSETDICLOFENAC 50 MG TABLETS DICLOSIF BATCHDICLOFENAC SODIUM BP 50 MG TABLET SIFED | $8.4M | 5 | 2.3% |
| 11 | BAL PHARMA LIMITED DICLOFENAC SODIUM WITH PARACETAMOL TABLEDICLOFENAC SODIUM AND PARACETAMOL TABLETPARACETAMOL, DICLOFENAC SODIUM AND MAGNE | $7.7M | 9 | 2.1% |
| 12 | SANGHARSH LIFECARE PRIVATE LIMITED DICLOFENAC SODIUM 50MG TABLET- DICLOSETDICLOFENAC 50 MG TABLETS DICLOSIF BATCHDICLOFENAC SODIUM BP 50 MG TABLET SIFED | $7.2M | 3 | 2.0% |
| 13 | DR REDDYS LABORATORIES LIMITED DICLOFENAC SODIUM AND PARACETAMOL TABLETPARACETAMOL, DICLOFENAC SODIUM AND MAGNEDICLOFENAC SODIUM 50MG TABLET- DICLOSET | $5.9M | 1 | 1.6% |
| 14 | ALEMBIC PHARMACEUTICALS LIMITED 300036534 DICLOFENAC SODIUM TOPICAL GEL1% 100GM | $4.7M | 1 | 1.3% |
| 15 | SOCOMED PHARMA PRIVATE LIMITED DICLOFENAC SODIUM WITH PARACETAMOL TABLEDICLOFENAC SODIUM 50MG TABLET- DICLOSETDICLOFENAC GEL BP 1% W/V (9 | $3.2M | 11 | 0.9% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Diclofenac exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Lincoln Pharmaceuticals Ltd | Not Listed | Yes | Yes | Not verified | Manufacturing facilities certified by WHO-GMP and EU GMP. |
| Rubicon Research Private Limited | Approved | Unknown | Unknown | 1 | Received FDA approval for Ivermectin Tablets USP, 6 mg, on January 22, 2025. |
| Cipla Limited | Approved | Unknown | Unknown | Multiple | Received FDA approval for Potassium Phosphates Injection USP on January 24, 2025 |
| Dr. Reddy's Laboratories Ltd | Approved | Unknown | Unknown | Not verified | FDA inspections conducted; specific outcomes not detailed. |
| Alembic Pharmaceuticals Limited | Approved | Unknown | Unknown | Multiple | Received multiple FDA approvals for generic medicines between 2024 and 2025. |
| Combitic Global Caplet Private Limited | Not Listed | Unknown | Unknown | Not verified | Blacklisted by the Indian government for failing to meet quality standards. |
| Encube Ethicals Private Limited | Approved | Unknown | Unknown | 1 | Received FDA approval for Nitroglycerin Ointment USP, 0.4%, on December 16, 2024 |
| Micro Labs Limited | Approved | Unknown | Unknown | Multiple | Received multiple FDA approvals for generic medicines. |
TransData Nexus reviewed the regulatory standing of 8 leading Diclofenac exporters from India. 6 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 1 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Diclofenac sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% to the nation's bulk drug production. The city hosts more than 2,000 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. The Hyderabad Pharma City project, recognized as a National Investment Manufacturing Zone in December 2019, aims to further bolster this sector.
The region's robust infrastructure and skilled workforce make it a prime location for manufacturing Active Pharmaceutical Ingredients (APIs) like Diclofenac. Companies such as A.R. Life Sciences and Hy-Gro Chemicals are notable API manufacturers in Hyderabad.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a significant hub for pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara being central to this output.
Vadodara is home to Alembic Pharmaceuticals, a company with a strong presence in the pharmaceutical industry. Additionally, companies like Mercury Laboratories Limited in Vadodara and Wellmed Pharma in the region contribute to the production of various pharmaceutical formulations.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to global markets. The region hosts numerous pharmaceutical companies, including those with manufacturing facilities in both Mumbai and Hyderabad, such as Formel Labs.
The strategic location and well-established logistics infrastructure make this cluster vital for the distribution and export of pharmaceuticals, including Diclofenac formulations.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh is known for its tax incentives, attracting numerous pharmaceutical companies. The region offers benefits like excise duty exemptions and income tax holidays, making it an attractive destination for pharmaceutical manufacturing. Companies like Theon Pharmaceuticals, based in Baddi, provide contract manufacturing services across India, including Gujarat.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and compliance standards of suppliers in Hyderabad, Ahmedabad-Vadodara, and Mumbai-Thane-Raigad clusters to ensure consistent quality.
- Leverage Export Infrastructure: Utilize the export facilities in the Mumbai-Thane-Raigad region to streamline logistics and reduce lead times for international shipments.
- Monitor Regulatory Compliance: Ensure that suppliers adhere to international regulatory standards, especially when exporting to major markets like the United States and the European Union.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Diclofenac exporters from India
Caplin Point Laboratories Limited — Caplin Point acquires 10 approved ANDAs to expand U.S. market presence
Caplin Point Laboratories Limited announced the acquisition of ten approved Abbreviated New Drug Applications (ANDAs) for injectable and ophthalmic products from a leading multinational generic pharmaceuticals manufacturer. This portfolio targets an addressable market of approximately USD 473.2 million for the 12-month period ending August 2025. - IMPACT: This strategic acquisition is expected to enhance Caplin Point's product offerings in the U.S., potentially increasing Diclofenac exports to the region.
Impact: This strategic acquisition is expected to enhance Caplin Point's product offerings in the U.S., potentially increasing Diclofenac exports to the region.
Common Questions — Diclofenac Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which diclofenac supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, LINCOLN PHARMACEUTICALS LTD leads with 179 recorded shipments worth $56.3M. COMBITIC GLOBAL CAPLET PRIVATE LIMITED (216 shipments) and RUBICON RESEARCH PRIVATE LIMITED (93 shipments) are also established high-volume exporters.
Q How many diclofenac manufacturers are there in India?
India has 1007 active diclofenac exporters with a combined export market of $363.9M across 15,000 shipments to 173 countries. The top 5 suppliers hold 42.3% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for diclofenac from India?
Average FOB unit price: $12.24 per unit, ranging from $0.00 to $5035.41. Average shipment value: $24.3K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 1007 verified Indian exporters of Diclofenac ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 15,000 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 173 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
1007 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists